So predictable, they keep writing the same chapter!23 Feb 2026 21:29
Omni-health (a company patently lacking expertise in this area, with limited reach presently) struggling to validate. How do I know? Self explaining really. They’ve been at it months with the ‘help’ of our team, when validating shouldn’t take this long. Also the recent Linkedin post about how they’ve only just achieved ability to produce tests. Hmmm.
Allan Syms untruthful again about time frames, re: coming to market 2025.
(A video has him saying “very near term” in 2023, then RNS stating April 2025, then end year 2025, now Q2 2026…right, Alan! What a Billshuttter he is.
IgenomeX - zero explanation.
Alan - if you don’t know the time frame, don’t make it up; haven’t you learned yet? (I don;t think yoiu care actually).
You have the veracity and dynamics of S’Keir Starmer. Obviously a bloke who drives at 30mph in a 50mph zone and can’t change gear.
Ciz Bio US obviously struggling with funds to pay Ciz UK in timely manner (oh, this is Oh so predictable people!) Fundraise coming in April imo (probs between £250K and £500K imo - Green, ‘assuming’ again! About Langs. Maybe, but Assume - makes an ass of you and me.
So Q2 now? April to end June, IF you believe them.
Another RNS that informed about absolutely NOTHING. Obvious pressure from shareholders pushed them to a non-event RNS.
Took a few K off the table today to de-risk. Still got half in. Might buy more if fundraise comes in at circa 1p to 1.2p. I think price will slip anyway, but I could be wrong.
Good luck all, in the ‘never never’ company.
Ps and all that guff about extended funding to 2031!
The test and company will probably be obsolete by then folks. What a load of rot!